Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
1 other identifier
observational
38
1 country
1
Brief Summary
The main objective of the study is to assess the effectiveness of the sheathed speculum in providing adequate visualization and access to the cervix in patients with excessive vaginal tissue. The secondary objective is to rate the patient's comfort evaluation during the sheathed speculum examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 2, 2011
CompletedFirst Posted
Study publicly available on registry
August 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedApril 23, 2013
April 1, 2013
4.8 years
August 2, 2011
April 22, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients with adequate visualization and access to cervix or vaginal vault
At time of speculum exam
Eligibility Criteria
excessive vaginal tissue
You may qualify if:
- Age 18 to 64 years
- BMI greater than 30 (or see next line)
- Collapsing vaginal tissue preventing the visualization of the cervix (meeting this criterion in the absence of a BMI \>30 would also qualify the patient for the study).
- Able to provide written informed consent
You may not qualify if:
- Patients unwilling to participate in the study or provide consent Presence of significant acute pelvic pain syndromes (ie exacerbation of dyspareunia, chronic pelvic pain or pelvic floor dysfunction, atrophic vaginitis, interstitial cystitis, endometriosis) which, in the opinion of the examining clinician, could potentially confound the patient's responses to the questionnaire
- Presence of active genital herpes
- Presence of significant condyloma acuminata (may be an investigator decision)
- Any other patient deemed inappropriate for the study by the consenting or examining investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USF STC
Tampa, Florida, 33549, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erich Wyckoff, M
University of South Florida
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2011
First Posted
August 4, 2011
Study Start
June 1, 2008
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
April 23, 2013
Record last verified: 2013-04